Skip to main content
Premium Trial:

Request an Annual Quote

Macrogen Launches Axeq Tech Division for Sequencing Services

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Korean biotechnology firm Macrogen today announced the creation of its US-based division Axeq Technologies to provide next-generation sequencing services.

Based in Rockville, Md., Axeq also has offices in Amsterdam, Tokyo, and Seoul, South Korea. It offers a variety of DNA sequencing services, including exome, whole genome, targeted, pooled, RNA, transcriptome, and ChIP sequencing, it said in a statement.

According to its website, exome sequencing services start at $1,999 per sample.

Instrument and sample preparation platforms being used include those from Illumina, Life Technologies, Roche 454, Agilent Technologies, and Roche Nimblegen. The firm said it has developed a large sequencing capacity, with the ability, for example, to sequence more than 100,000 exome sequences each year.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.